G40.84
KCNQ2-related epilepsy
Clinical Classification Guidelines
Medical Intelligence & Overview
KCNQ2-related epilepsy is a neurological condition caused by mutations in the KCNQ2 gene. This gene plays a vital role in controlling electrical activity in the brain, and its dysfunction can lead to seizures. The condition encompasses a range of seizure disorders that typically begin in infancy or early childhood. Recognizing the features of KCNQ2-related epilepsy helps in proper diagnosis and management, although the specific treatment strategies may vary based on individual symptoms and severity.
Causes & Symptoms
Clinical Causes: Genetic mutations in the KCNQ2 gene, often inherited in an autosomal dominant manner De novo mutations occurring spontaneously without a family history No known environmental or lifestyle factors have been definitively linked to this condition
Key Symptoms: Seizures beginning in the early stages of life, often within the first few months Variety in seizure types, including focal seizures and neonatal seizures Episodes may include abnormal movements, stiffening, or rhythmic jerking Possible developmental delays or progressions depending on severity Some children may experience seizure remission over time, while others may have persistent epilepsy
Diagnostic & Treatment
Diagnosis Path: Review the patient’s medical history, especially early onset seizures Perform neurological examinations Order EEGs (electroencephalograms) to detect abnormal electrical activity in the brain Conduct genetic testing to identify mutations in the KCNQ2 gene Rule out other causes of neonatal and early childhood seizures
Treatment Protocols: Antiepileptic medications, such as sodium channel blockers or other seizure medications, tailored to the individual’s response Supportive therapies, including physical, occupational, or speech therapy for developmental support Regular neurological assessments to monitor seizure activity and developmental progress Management of associated issues like developmental delays or behavioral challenges
Clinical Advice & FAQs
Billing Guidance
Is G40.84 a billable ICD-10 code?
Yes, G40.84 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G40.84?
Clinical documentation must specify the nature of KCNQ2-related epilepsy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference